Research & Literature

Headache and Pain in Guillain-Barré Syndrome.

Farmakidis C, Inan S, Milstein M, Herskovitz S

Current pain and headache reports 2015; (19(8)):40 doi:10.1007/s11916-015-0508-x.

Therapeutic plasma exchange as a therapeutic modality for the treatment of IVIG complications.

Welsh KJ, Bai Y

Journal of clinical apheresis 2015; (30(6)):371-4 doi:10.1002/jca.21386.

Subtypes and Prognosis of Guillain-Barré Syndrome in Southwest China.

Zhang G, Li Q, Zhang R, et al.

PloS one 2015; (10(7)):e0133520 doi:10.1371/journal.pone.0133520.

[Target Molecule for a Demyelinating Type of Guillain-Barré Syndrome, Acute Inflammatory Demyelinating Polyneuropathy].

Mori M

Brain and nerve = Shinkei kenkyu no shinpo 2015; (67(11)):1359-69 doi:10.11477/mf.1416200306.

Acute Motor Axonal Neuropathy (Aman) With Motor Conduction Blocks In Childhood; Case Report.

Yildirim S, Adviye R, Gül HL, Türk Börü Ü

Iranian journal of child neurology 2016; (10(1)):65-9.

[Electrophysiological subtypes and long term prognosis of Guillain-Barré syndrome].

Zhang J, Song XJ, Hou HQ, et al.

Zhonghua yi xue za zhi 2016; (96(25)):1987-90 doi:10.3760/cma.j.issn.0376-2491.2016.25.006.

Guillain-Barré syndrome in Bangladesh: validation of Brighton criteria.

Islam MB, Islam Z, Farzana KS, et al.

Journal of the peripheral nervous system : JPNS 2016; (21(4)):345-351 doi:10.1111/jns.12189.

Differentiating Familial Neuropathies from Guillain-Barré Syndrome.

Bordini BJ, Monrad P

Pediatric clinics of North America 2017; (64(1)):231-252 doi:10.1016/j.pcl.2016.08.015.

Diabetes mellitus may affect short-term outcome of Guillain-Barré syndrome.

Peric S, Bozovic I, Bjelica B, et al.

Journal of the peripheral nervous system : JPNS 2017; (22(2)):127-130 doi:10.1111/jns.12206.

Plasma exchange for Guillain-Barré syndrome.

Chevret S, Hughes RA, Annane D

The Cochrane database of systematic reviews 2017; (2()):CD001798 doi:10.1002/14651858.CD001798.pub3.

International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome.

Jacobs BC, van den Berg B, Verboon C, et al.

Journal of the peripheral nervous system : JPNS 2017; (22(2)):68-76 doi:10.1111/jns.12209.

Role of "Sural Sparing" Pattern (Absent/Abnormal Median and Ulnar with Present Sural SNAP) Compared to Absent/Abnormal Median or Ulnar with Normal Sural SNAP in Acute Inflammatory Demyelinating Polyneuropathy.

Surpur SS, Govindarajan R

Frontiers in neurology 2017; (8()):512 doi:10.3389/fneur.2017.00512.

Clinical Significance of A Waves in Acute Inflammatory Demyelinating Polyradiculoneuropathy.

Lakshminarasimhan S, Venkatraman C, Vellaichamy K, Ranganathan L

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2018; (35(5)):415-418 doi:10.1097/WNP.0000000000000480.

Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU.

Das S, Khan RK, Alam SM, et al.

Mymensingh medical journal : MMJ 2018; (27(3)):631-640.

Cost-minimization analysis in the Indian subcontinent for treating Guillain Barre Syndrome patients with therapeutic plasma exchange as compared to intravenous immunoglobulin.

Maheshwari A, Sharma RR, Prinja S, et al.

Journal of clinical apheresis 2018; (33(6)):631-637 doi:10.1002/jca.21646.

Ultrastructural mechanisms of macrophage-induced demyelination in CIDP.

Koike H, Nishi R, Ikeda S, et al.

Neurology 2018; (91(23)):1051-1060 doi:10.1212/WNL.0000000000006625.

How Different is AMAN from AIDP in Childhood GBS? A Prospective Study from North India.

Gupta PK, Singhi P, Singhi S, et al.

Indian journal of pediatrics 2019; (86(4)):329-334 doi:10.1007/s12098-018-2835-5.

Differentiation Between Guillain-Barré Syndrome and Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuritis-a Prospective Follow-up Study Using Ultrasound and Neurophysiological Measurements.

Grimm A, Oertl H, Auffenberg E, et al.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2019; (16(3)):838-847 doi:10.1007/s13311-019-00716-5.

Clinical Features and the Validation of the Brighton Criteria in Guillain-Barré Syndrome: Retrospective Analysis of 72 Hospitalized Patients in Three Years.

Zeng Y, Liu Y, Xie Y, et al.

European neurology 2019; (81(5-6)):231-238 doi:10.1159/000503101.

Guillain-Barre Syndrome.

Malek E, Salameh J

Seminars in neurology 2019; (39(5)):589-595 doi:10.1055/s-0039-1693005.

Clinical Features Indicating the Need for Mechanical Ventilation in Patients with Guillain Barre Syndrome.

Umer SR, Nisa Q, Kumari M, et al.

Cureus 2019; (11(8)):e5520 doi:10.7759/cureus.5520.

Nationwide study of therapeutic plasma exchange vs intravenous immunoglobulin in Guillain-Barré syndrome.

Beydoun HA, Beydoun MA, Hossain S, et al.

Muscle & nerve 2020; (61(5)):608-615 doi:10.1002/mus.26831.

Guillain-Barré syndrome complicated by takotsubo cardiomyopathy: an under-recognised association.

Jones T, Umaskanth N, De Boisanger J, Penn H

BMJ case reports 2020; (13(2)) doi:10.1136/bcr-2019-233591.

Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barré syndrome.

Koike H, Fukami Y, Nishi R, et al.

Journal of neurology, neurosurgery, and psychiatry 2020; (91(6)):650-659 doi:10.1136/jnnp-2019-322479.

COVID-19-Associated Miller Fisher Syndrome: MRI Findings.

Lantos JE, Strauss SB, Lin E

AJNR. American journal of neuroradiology 2020; (41(7)):1184-1186 doi:10.3174/ajnr.A6609.

Rate of progression of Guillain-Barré syndrome is not associated with the short-term outcome of the disease.

Arsenijević M, Berisavac I, Mladenović B, et al.

Irish journal of medical science 2021; (190(1)):357-361 doi:10.1007/s11845-020-02310-7.

[Successful treatment of Guillain-Barré syndrome-like acute inflammatory demyelinating polyneuropathy caused by pembrolizumab with a combination of corticosteroid and immunoglobulins: a case report].

Hashimoto R, Ueda T, Tsuji Y, et al.

Rinsho shinkeigaku = Clinical neurology 2020; (60(11)):773-777 doi:10.5692/clinicalneurol.cn-001444.

Miller Fisher Variant of Guillain-Barré Syndrome: A Great Masquerader.

Urlapu KS, Saad M, Bhandari P, et al.

Cureus 2020; (12(10)):e11045 doi:10.7759/cureus.11045.

Acute-onset chronic inflammatory demyelinating polyneuropathy with cranial nerves and respiratory tract involvement: A case report.

Mansour M, Ouerdiene A, Bedoui I, et al.

Clinical case reports 2020; (8(11)):2199-2203 doi:10.1002/ccr3.3087.

Comparative study of various therapeutic modalities for Guillain Barré syndrome in Assiut University Children Hospital.

Mohy-Eldeen ZM, Ahmad AR, Mahran HH, Saad K

The Turkish journal of pediatrics 2020; (62(6)):962-969.

Clinical Outcome of Guillain-Barré Syndrome in 108 Children.

Sen S, Kumar A, Roy B

Indian pediatrics 2021; (58(9)):833-835.

Complication of Hepatitis A Infection: Case Report of Acute Inflammatory Demyelinating Polyneuropathy.

Laursen D, Krug J, Wolford R

Clinical practice and cases in emergency medicine 2021; (5(1)):113-116 doi:10.5811/cpcem.2020.9.48827.

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.

Walgaard C, Jacobs BC, Lingsma HF, et al.

The Lancet. Neurology 2021; (20(4)):275-283 doi:10.1016/S1474-4422(20)30494-4.

Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study.

Alanazy MH, Bakry SS, Alqahtani A, et al.

BMC neurology 2021; (21(1)):275 doi:10.1186/s12883-021-02314-5.

Spectrum of Acute Neuropathy Associated With Covid-19: A Clinical and Electrophysiological Study of 13 Patients From a Single Center.

Yaranagula SD, Koduri VKC

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2021; (110()):314-319 doi:10.1016/j.ijid.2021.07.066.

Pain in acute motor axonal neuropathy.

Zhao F, Wang J, Zhang J, et al.

Muscle & nerve 2021; (64(6)):739-743 doi:10.1002/mus.27414.

Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.

Doets AY, Lingsma HF, Walgaard C, et al.

Neurology 2022; (98(5)):e518-e532 doi:10.1212/WNL.0000000000013139.

International Validation of the Erasmus Guillain-Barré Syndrome Respiratory Insufficiency Score.

Doets AY, Walgaard C, Lingsma HF, et al.

Annals of neurology 2022; (91(4)):521-531 doi:10.1002/ana.26312.

Electrophysiological Pattern and Predictors of Functional Outcome of Patients with Guillain Barre Syndrome at a Tertiary Care Hospital in Pakistan.

Siddiqui M, Majid S, Yusuf H, Mateen F

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2022; (32(3)):364-368 doi:10.29271/jcpsp.2022.03.364.

Clinical predictors and electrodiagnostic characteristics in patients with Guillain-Barré syndrome with respiratory failure: a retrospective, matched case-control study.

Charoentanyarak K, Singjam A, Saengsuwan J

PeerJ 2022; (10()):e12930 doi:10.7717/peerj.12930.

Risk Factors for Mechanical Ventilation in Patients with Guillain-Barré Syndrome.

Cheng Y, Liu K, Li C, et al.

Neurocritical care 2022; (37(1)):121-128 doi:10.1007/s12028-022-01457-8.

Prognostic Implications of Early Albuminocytological Dissociation in Guillain-Barré Syndrome.

Vargas-Cañas ES, Galnares-Olalde JA, León-Velasco F, et al.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2023; (50(5)):745-750 doi:10.1017/cjn.2022.288.

Study of total duration of distal compound muscle action potential in demyelinating and axonal Guillain-Barre' syndrome.

Ginanneschi F, Cioncoloni D, Capoccitti G, et al.

Neurological research 2023; (45(4)):381-389 doi:10.1080/01616412.2022.2148517.

Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome.

Luijten LWG, Doets AY, Arends S, et al.

Journal of neurology, neurosurgery, and psychiatry 2023; (94(4)):300-308 doi:10.1136/jnnp-2022-329937.

CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome.

Al-Hakem H, Doets AY, Stino AM, et al.

Neurology 2023; (100(23)):e2386-e2397 doi:10.1212/WNL.0000000000207282.

Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.

Dziadkowiak E, Nowakowska-Kotas M, Rałowska-Gmoch W, et al.

International journal of molecular sciences 2023; (24(11)) doi:10.3390/ijms24119180.

Guillain-Barre Syndrome in Children and Adolescents.

Langille MM

Advances in pediatrics 2023; (70(1)):91-103 doi:10.1016/j.yapd.2023.04.001.

Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee.

Tavee J, Brannagan TH, Lenihan MW, et al.

Muscle & nerve 2023; (68(4)):356-374 doi:10.1002/mus.27922.

Early electrophysiological study variants and their relationship with clinical presentation and outcomes of patients with Guillain-Barré syndrome.

Khedr EM, Shehab MM, Mohamed MZ, Mohamed KO

Scientific reports 2023; (13(1)):14000 doi:10.1038/s41598-023-41072-x.

European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.

van Doorn PA, Van den Bergh PYK, Hadden RDM, et al.

European journal of neurology 2023; (30(12)):3646-3674 doi:10.1111/ene.16073.

Factors Associated with Respiratory Insufficiency in Children with Guillain-Barré Syndrome.

Sun RD, Jiang J, Deng XL

Neuropediatrics 2024; (55(2)):112-116 doi:10.1055/s-0043-1777767.

Assessing the comparative efficacy of plasmapheresis and Intravenous immunoglobulin in myasthenia gravis treatment: A systematic review and meta-analysis.

Ghimire A, Kunwar B, Aryal B, et al.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2024; (121()):1-10 doi:10.1016/j.jocn.2024.01.025.

A Study of Sensory Nerve Conduction in Pre- and Post-immunoglobulin Treatment of Guillain-Barré Syndrome.

A P, Shende V, Pawar S

Cureus 2024; (16(1)):e51673 doi:10.7759/cureus.51673.

Efficacy and safety of intravenous immunoglobulin retreatment amongst Guillain-Barré syndrome patients who poorly responded to initial IVIG cycle: a systematic review.

Prado MB, Adiao KJB, Turalde CWR, Dasig DA

Acta neurologica Belgica 2024; (124(4)):1237-1250 doi:10.1007/s13760-024-02518-9.

Treatment Efficacy of Plasmapheresis Versus Intravenous Immunoglobulin in Guillain-Barré Syndrome Management: A Systematic Review.

Savithri Nandeesha S, Kasagga A, Hawrami C, et al.

Cureus 2024; (16(3)):e57066 doi:10.7759/cureus.57066.

Effect of intravenous immunoglobulin and plasmapheresis on nerve conduction parameters compared to the natural course of Guillain-Barré syndrome.

Kalita J, Mahajan R, Kumar M

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2024; (125()):76-82 doi:10.1016/j.jocn.2024.05.016.

Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.

Neurology 2024; (103(9)):e209968 doi:10.1212/WNL.0000000000209968.

Diagnostic criteria and therapeutic implications of rapid-onset demyelinating polyneuropathies.

Rałowska-Gmoch W, Koszewicz M, Łabuz-Roszak B, et al.

Experimental and molecular pathology 2024; (140()):104942 doi:10.1016/j.yexmp.2024.104942.

Risk factors of disease severity and mechanical ventilation requirement in childhood Guillain-Barré Syndrome.

Yücel G, Arslan AK, Özgör B, Güngör S

The Turkish journal of pediatrics 2024; (66(6)):746-757 doi:10.24953/turkjpediatr.2024.4658.

Plasma exchange alone versus combination with intravenous immunoglobulin/methylprednisolone pulse therapy in severe systemic rheumatic diseases: a retrospective study.

Guo J, Li S, Xu H, et al.

Frontiers in immunology 2024; (15()):1454691 doi:10.3389/fimmu.2024.1454691.

Albuminocytologic Dissociation and the Impact of Age-Adjusted Cerebrospinal Fluid Protein Levels in Guillain-Barré Syndrome.

Thatikonda N, Lerint A, Takle C, et al.

Neurology international 2025; (17(2)) doi:10.3390/neurolint17020018.

Clinical study of the relationship between hepatitis B core antibody and mechanical ventilation in patients with Guillain-Barré syndrome.

Zhang W, Yao Q, Wang Y, et al.

Frontiers in neurology 2025; (16()):1530286 doi:10.3389/fneur.2025.1530286.

Clinico-epidemiological profile and prediction of outcome in children with Guillain-Barre syndrome.

Priyadarshini D, Anuhya V, Mahapatra A

Italian journal of pediatrics 2025; (51(1)):179 doi:10.1186/s13052-025-02037-0.

Integrated treatment approach to Miller Fisher syndrome, a variant of Guillain-Barre syndrome - A case report.

Yadav P, Vaishali Kuchewar , Bhusari N, Yadav T

Journal of Ayurveda and integrative medicine 2025; (16(4)):101159 doi:10.1016/j.jaim.2025.101159.

A propensity score matched retrospective study of psychological and behavioral therapy impact on muscle function recovery in Guillain Barré Syndrome.

Lu Z, Xie X, Rui Z, et al.

Scientific reports 2025; (15(1)):31880 doi:10.1038/s41598-025-16482-8.

Neuronal inflammation-associated biomarkers in cerebrospinal fluid of patients with acute and chronic inflammatory demyelinating polyneuropathies.

Atasever Ü, Akünal C, Soytürk H

Journal of neuroimmunology 2025; (409()):578756 doi:10.1016/j.jneuroim.2025.578756.

Neurofilament Light Chain Levels as Diagnostic and Prognostic Biomarkers in Guillain-Barré Syndrome: An Updated Systematic Review and Meta-Analysis.

Siconolfi G, Vitali F, Sciarrone MA, et al.

Neurology and therapy 2025; (14(6)):2387-2410 doi:10.1007/s40120-025-00830-x.

Polyradiculoneuropathies associated with immune checkpoint inhibitors: are we facing a new nosological entity?

Trimboli M, Marino L, Iusi IC, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(12)):6479-6489 doi:10.1007/s10072-025-08422-1.

[Immune-mediated polyneuropathies].

Cerezo S, Expósito J, Carrera L, et al.

Medicina 2025; (85 Suppl 4()):41-46.

Peripheral nerve-targeting and pain-promoting transcriptomic signatures in early Guillain-Barré syndrome.

O'Brien JA, Lesnak JB, Sankaranarayanan I, et al.

bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.09.24.678413.

Guillain-Barré Syndrome with Discharges Following Compound Muscle Action Potentials: A-waves, M Dispersion or After-Discharges?

Baslo SA, Karaağaç N, Öge AE

Noro psikiyatri arsivi 2025; (62(4)):393-397 doi:10.29399/npa.28925.

Fine Motor Outcomes in Children with Guillain-Barré Syndrome.

Kumar A, Saini L, Gunasekaran PK, et al.

Indian journal of pediatrics 2026; (93(3)):282-287 doi:10.1007/s12098-025-05891-2.

Utility of the "Modified Erasmus GBS Respiratory Insufficiency Score" in Axonal and Demyelinating Guillain-Barré Syndrome.

Sekiguchi Y, Misawa S, Morooka M, et al.

Journal of the peripheral nervous system : JPNS 2026; (31(1)):e70096 doi:10.1111/jns.70096.

Augmented reality assisted physiotherapy rehabilitation in early phase of guillain barre syndrome (AIDP)-a case report.

Shah R, Samal S

BMC neurology 2026; (26(1)).